Prof. Antonio Lanzavecchia receives the 2017 Sanofi - Institut Pasteur Award
The award recognizes investigators for past or ongoing work demonstrating real scientific progress in the life sciences. Antonio Lanzavecchia was rewarded for his research on the role of human monoclonal antibodies in the fight against malaria.
Antonio Lanzavecchia received the international award along with Michel C. Nussenzweig from the Rockefeller University and Jeffrey I. Gordon of Washington University. The three laureates, together with two national junior award recipients, received their awards during a ceremony that took place on December 12th at the Institut Pasteur in Paris.
Prof. Antonio Lanzavecchia is Director of the Institute for Research in Biomedicine (IRB) in Bellinzona and Professor emeritus at ETH Zürich, Institute of Microbiology.
Created in 2012, the Sanofi – Institut Pasteur Awards are the result of a historical and privileged collaboration between two partners, Sanofi and the Institut Pasteur, to promote and support scientific excellence and innovation in service of global health. The Jury is composed of esteemed members, all of them recipients of distinguished prizes, including Nobel Prizes of Physiology and Medicine.
For more information, please refer to the external pageAward websitecall_made of the Institute Pasteur.
(external pageText based on a media release of the IRB.call_made)